InvestorsHub Logo
Followers 604
Posts 69362
Boards Moderated 1
Alias Born 01/09/2007

Re: None

Wednesday, 08/09/2017 9:27:36 AM

Wednesday, August 09, 2017 9:27:36 AM

Post# of 894
Merrimack Pharmaceuticals (NASDAQ:MACK): Q2 EPS of -$0.22 misses by $0.08.